EMP化疗方案在治疗妊娠滋养细胞肿瘤中的临床价值

彭程; 周颖; 张雪芬; 吴大保

doi:10.13898/j.cnki.issn.1000-2200.2017.06.028

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

EMP化疗方案在治疗妊娠滋养细胞肿瘤中的临床价值

彭程 , 周颖 , 张雪芬 , 吴大保

文章导航 > 蚌埠医学院学报 > 2017, 42 > 6: (784-786)

引用本文:

Citation:

EMP化疗方案在治疗妊娠滋养细胞肿瘤中的临床价值

安徽医科大学附属省立医院妇产科, 安徽合肥 230001

作者简介: 彭程(1981-),女,博士研究生,主治医师.

通讯作者: 吴大保, 主治医师.wudabao5907@126.com

基金项目:
安徽省科技攻关项目（1501041141）
中图分类号: R737.33

Clinical value of EMP chemotherapy program in the treatment of gestational tophoblastic neoplasia

Department of Obstetrics and Gynecology, Anhui Provincinal Hospital Affiliated to Anhui Medical University, Hefei Anhui 230001, China

Corresponding author: WU Da-bao, 主治医师.wudabao5907@126.com

CLC number: R737.33

摘要: 目的：探讨依托泊苷+甲氨蝶呤+铂类（EMP）化疗方案治疗妊娠滋养细胞肿瘤（GTN）的临床应用价值。方法：采用EMP方案化疗治疗GTN 22例，其中6例接受单纯EMP方案；16例采用EMP方案作为二线化疗，MTX单药作为初始化疗7例（31.8%），FAV方案作为初始化疗8例（36.4%），FAVE方案作为初始化疗4例（18.2%），EMA-CO方案作为初始化疗2例（9.1%），VMP方案作为初始化疗1例（4.5%）。1例在化疗基础上辅以手术治疗。结果：全部病人均达到血清学完全缓解，缓解率100%，其中单纯方案缓解率为37.5%；常见的不良反应依次为骨髓抑制、消化系统反应、脱发以及轻微肝肾毒性，差异有统计学意义（P<0.05）。1例化疗至第3疗程时出现Ⅳ度中性粒细胞减少，Ⅲ度血小板减少，予以集落刺激因子（G-CSF）及重组人白细胞介素-11治疗后缓解。随访22例，1例化疗疗程结束后2个月意外妊娠，人工流产后随访无异常，其余均正常。结论：EMP方案作为初始方案或是二线方案治疗GTN病人时疗效较满意，值得临床推广。
- 妊娠滋养细胞肿瘤 /
- 依托泊苷 /
- 甲氨蝶呤 /
- 铂类
Abstract: Objective: To discuss the clinical value of EMP(etoposide,methotrexate and platinum) chemotherapy in the treatment of gestational tophoblastic neoplasia(GTN). Methods: Twenty-two cases with GTN were treated with EMP program(including 6 cases treated with simple EMP program and EMP program as for second-line treatment in 16 cases).MTX as the initial chemotherapy in 7 cases(31.8%),FAV as the initial chemotherapy in 8 cases(18.2%),FAVE as the initial chemotherapy in 4 cases(18.2%),EMA-Co as the initial chemotherapy in 2 cases(9.1%) and VMP as the initial chemotherapy in 1 case(4.5%) were implemented.One cases were operated based on chemotherapy. Results: The serology index of all patients arrived at the complete alleviation,the alleviation rate of which was 100%(the simple program for 37.5%).The bone marrow suppression,digestive tract reaction,hair loss and slight hepatic and renal toxicity were the major adverse reactions,the difference of which was statistical significance(P<0.05).The IV degree neutropenia and Ⅲ degree thrombocytopenia in 1 case at three course of chemotherapy alleviated after the treatment with colony stimulating factor(CSF) and recombinant human interleukin-11.Twenty-two patients were followed up,the unintended pregnancy in 1 case after 2 months of chemotherapy was identified,who recovered normal after the abortion,and other cases were normal. Conclusions: The initial or second-line chemotherapy with EMP in the treatment of GTN is good effect,which is worthy of promotion.
- gestational trophoblastic neoplasia /
- etoposide /
- methotrexate /
- platinum

[1]	KOHORN EI.The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease:description and critical assessment[J].Int J Gynecol Cancer,2001,11(1):73.
[2]	SOPER JT,MUTCH DG,SCHINK JC.Diagnosis and treatment of gestational trophoblastic disease:ACOG Practice Bulletin No.53[J].Gye Oncol,2004,93(3):575.
[3]	WANG J,SHORT D,SEBIRE NJ, et al.Salvage chemotherapy relapsed or high-risk gestational trophoblastic neoplasia(GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide(TP/TE)[J].Ann Oncol,2008,19(9):1578.
[4]	ALAZZAM M,TIDY J,HANCOCK BW, et al.First-line chemotherapy in low-risk gestational trophoblastic neoplasia[J].Cochrane Database Syst Rev,2012,7:CD007102.
[5]	MCGRATH S,SHORT D,HARVEY R, et al.The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia,but hCG levels in excess of 100000 IU/L[J].Br J Cancer,2010,102(5):810.
[6]	向阳,宋鸿钊.滋养细胞肿瘤学[M].3版.北京:人民卫生出版社,2011:214.
[7]	MCNEISH IA,STRICKLAND S,HOLDEN L, et al.Low-risk persistent gestational trophoblastic disease:outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000[J].J Clin Oncol,2002,20(7):1838.
[8]	FENG F,XIANG Y,WAN X, et al.Salvage combination chemotherapy with floxuridine,dactinomycin,etoposide,and vincristine(FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia[J].Ann Oncol,2011,22(7):1588.
[9]	POWLES T,SAVAGE PM,STEBBING J, et al.A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia[J].Br J Cancer,2007,96(5):732.
[10]	肖长纪,向阳.耐药性妊娠滋养细胞肿瘤治疗的研究进展[J].中华妇产科杂志, 2015,50(9):712.
[11]	KIER MG,JOHANSEN C.Second malignant neoplasms and cause of death in patients with germ cell cancer:a danish nationwide cohort study[J].JAMA Oncol,2016,10(6):3561.

[1]	汪强武 , 王安潮 , 陈余清 . 端粒酶11-聚体寡核苷酸联合依托泊苷对肺癌细胞的作用. 蚌埠医学院学报, 2005, 30(3): 208-210.
[2]	郑家雷 , 方向 , 汪子书 . 大剂量甲氨蝶呤、顺铂联合阿霉素新辅助化疗骨肉瘤的近期疗效分析. 蚌埠医学院学报, 2015, 40(12): 1631-1634. doi: 10.13898/j.cnki.issn.1000-2200.2015.12.005
[3]	麻璨琛 . 白芍总苷联合甲氨蝶呤治疗类风湿关节炎疗效的Meta分析. 蚌埠医学院学报, 2016, 41(3): 329-332. doi: 10.13898/j.cnki.issn.1000-2200.2016.03.016
[4]	阮璐璐 . 超声介入引导下甲氨蝶呤局部注射联合口服米非司酮治疗子宫瘢痕妊娠的疗效观察. 蚌埠医学院学报, 2019, 44(9): 1230-1233. doi: 10.13898/j.cnki.issn.1000-2200.2019.09.024
[5]	向君华 . 大剂量甲氨蝶呤治疗儿童急性淋巴细胞白血病的不良反应临床观察. 蚌埠医学院学报, 2015, 40(5): 616-618. doi: 10.13898/j.cnki.issn.1000-2200.2015.05.018
[6]	王素侠 , 张华伟 , 郭琼 , 杜丹丽 . 妊娠滋养细胞肿瘤介入治疗的护理观察. 蚌埠医学院学报, 2010, 35(4): 418-420.
[7]	姚茹冰 , 高佩芳 , 蔡辉 . 甲氨蝶呤对类风湿关节炎CCP/AST分泌白介素-4及干扰素-γ水平的影响. 蚌埠医学院学报, 2011, 36(1): 49-51.
[8]	曲珣 . 子宫颈妊娠15例临床分析. 蚌埠医学院学报, 2011, 36(9): 1002-1003.
[9]	金涛 , 江谋应 , 徐万里 , 王金林 . 经子宫动脉介入治疗输卵管妊娠27例. 蚌埠医学院学报, 2010, 35(3): 292-294.
[10]	张长虹 , 王晖 . 多种方法在治疗剖宫产术后子宫瘢痕妊娠中的应用. 蚌埠医学院学报, 2014, 38(3): 339-342.
[11]	张文慧 , 李坚雄 , 马黛 . 子宫瘢痕妊娠3种治疗方案疗效观察. 蚌埠医学院学报, 2016, 41(4): 496-498,501. doi: 10.13898/j.cnki.issn.1000-2200.2016.04.023
[12]	陈学东 , 张华满 . 吉西他滨联合长春瑞滨治疗铂类耐药中晚期非小细胞肺癌23例. 蚌埠医学院学报, 2009, 34(7): 601-603.
[13]	孙翠玲 , 徐晓宇 , 高莹莹 , 谢小缺 , 胡文军 . 培美曲赛联合铂类治疗晚期非小细胞肺癌的安全性和有效性观察. 蚌埠医学院学报, 2015, 40(6): 754-756. doi: 10.13898/j.cnki.issn.1000-2200.2015.06.018
[14]	王素侠 , 郭琼 , 史倩 . 妊娠性滋养细胞肿瘤患者200例整体护理体会. 蚌埠医学院学报, 2006, 31(1): 101-102.
[15]	章雪莲 . 甲氨喋呤和米非司酮联用治疗异位妊娠疗效观察. 蚌埠医学院学报, 2004, 29(6): 533-534.
[16]	毛国顺 , 郭玉淮 , 赵永 , 李岩 . 大剂量甲氨喋呤治疗儿童急性淋巴细胞白血病毒副作用观察. 蚌埠医学院学报, 2004, 29(4): 339-340.
[17]	曹静 , 罗时成 , 谈笑 , 程月 . 黄芪甲苷对成纤维细胞的毒性研究. 蚌埠医学院学报, 2021, 46(11): 1500-1506. doi: 10.13898/j.cnki.issn.1000-2200.2021.11.002
[18]	齐晓艳 , 张波 , 余美玲 , 陶亮 , 张翠玲 . 三七皂苷R1通过细胞缝隙连接对顺铂细胞毒性作用的影响. 蚌埠医学院学报, 2012, 36(2): 134-137.
[19]	李靖 , 郑旭薇 , 贾建光 , 郭晨旭 , 金鑫 , 钱军 . 人参皂苷Rh2对低浓度的奥沙利铂诱导人胃癌SGC-7901侧群细胞凋亡的增敏作用. 蚌埠医学院学报, 2018, 43(5): 561-566,572. doi: 10.13898/j.cnki.issn.1000-2200.2018.05.001
[20]	刘静波 , 郭晨旭 , 马玲 . 人参皂苷Rg1联合奈达铂通过Hedgehog通路抑制卵巢癌细胞OVCAR-3的增殖及机制探究. 蚌埠医学院学报, 2020, 45(4): 442-446. doi: 10.13898/j.cnki.issn.1000-2200.2020.04.006

点击查看大图

计量

文章访问数: 3780
HTML全文浏览量: 437
PDF下载量: 81
被引次数: 0

EMP化疗方案在治疗妊娠滋养细胞肿瘤中的临床价值

通讯作者: 吴大保, 主治医师.wudabao5907@126.com

作者简介: 彭程(1981-),女,博士研究生,主治医师.

安徽医科大学附属省立医院妇产科, 安徽合肥 230001

收稿日期: 2017-02-28

基金项目: 安徽省科技攻关项目（1501041141）

关键词:

摘要: 目的：探讨依托泊苷+甲氨蝶呤+铂类（EMP）化疗方案治疗妊娠滋养细胞肿瘤（GTN）的临床应用价值。方法：采用EMP方案化疗治疗GTN 22例，其中6例接受单纯EMP方案；16例采用EMP方案作为二线化疗，MTX单药作为初始化疗7例（31.8%），FAV方案作为初始化疗8例（36.4%），FAVE方案作为初始化疗4例（18.2%），EMA-CO方案作为初始化疗2例（9.1%），VMP方案作为初始化疗1例（4.5%）。1例在化疗基础上辅以手术治疗。结果：全部病人均达到血清学完全缓解，缓解率100%，其中单纯方案缓解率为37.5%；常见的不良反应依次为骨髓抑制、消化系统反应、脱发以及轻微肝肾毒性，差异有统计学意义（P<0.05）。1例化疗至第3疗程时出现Ⅳ度中性粒细胞减少，Ⅲ度血小板减少，予以集落刺激因子（G-CSF）及重组人白细胞介素-11治疗后缓解。随访22例，1例化疗疗程结束后2个月意外妊娠，人工流产后随访无异常，其余均正常。结论：EMP方案作为初始方案或是二线方案治疗GTN病人时疗效较满意，值得临床推广。

English Abstract

Clinical value of EMP chemotherapy program in the treatment of gestational tophoblastic neoplasia

Corresponding author: WU Da-bao, 主治医师.wudabao5907@126.com

Department of Obstetrics and Gynecology, Anhui Provincinal Hospital Affiliated to Anhui Medical University, Hefei Anhui 230001, China

Received Date: 2017-02-28

Abstract: Objective: To discuss the clinical value of EMP(etoposide,methotrexate and platinum) chemotherapy in the treatment of gestational tophoblastic neoplasia(GTN). Methods: Twenty-two cases with GTN were treated with EMP program(including 6 cases treated with simple EMP program and EMP program as for second-line treatment in 16 cases).MTX as the initial chemotherapy in 7 cases(31.8%),FAV as the initial chemotherapy in 8 cases(18.2%),FAVE as the initial chemotherapy in 4 cases(18.2%),EMA-Co as the initial chemotherapy in 2 cases(9.1%) and VMP as the initial chemotherapy in 1 case(4.5%) were implemented.One cases were operated based on chemotherapy. Results: The serology index of all patients arrived at the complete alleviation,the alleviation rate of which was 100%(the simple program for 37.5%).The bone marrow suppression,digestive tract reaction,hair loss and slight hepatic and renal toxicity were the major adverse reactions,the difference of which was statistical significance(P<0.05).The IV degree neutropenia and Ⅲ degree thrombocytopenia in 1 case at three course of chemotherapy alleviated after the treatment with colony stimulating factor(CSF) and recombinant human interleukin-11.Twenty-two patients were followed up,the unintended pregnancy in 1 case after 2 months of chemotherapy was identified,who recovered normal after the abortion,and other cases were normal. Conclusions: The initial or second-line chemotherapy with EMP in the treatment of GTN is good effect,which is worthy of promotion.